---
figid: PMC6942807__JO2019-5956867.004
figtitle: A strategic proposal for enhancing tumor sensitivity to radiation via inhibiting
  mTOR signaling
organisms:
- NA
pmcid: PMC6942807
filename: JO2019-5956867.004.jpg
figlink: /pmc/articles/PMC6942807/figure/fig4/
number: F4
caption: A strategic proposal for enhancing tumor sensitivity to radiation via inhibiting
  mTOR signaling. Activated mTORC1 signaling in tumors might effectively eliminate
  radiation-induced ROS through promoting antioxidant mechanisms. However, inhibiting
  mTOR signaling might attenuate the antioxidant KEAP1-NRF2 pathway. Therefore, blockade
  of mTOR signaling in tumors might be an alternative strategy to increase tumor susceptibility
  to radiation.
papertitle: mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance.
reftext: Yunseo Woo, et al. J Oncol. 2019;2019:5956867.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9501736
figid_alias: PMC6942807__F4
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC6942807__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6942807__JO2019-5956867.004.html
  '@type': Dataset
  description: A strategic proposal for enhancing tumor sensitivity to radiation via
    inhibiting mTOR signaling. Activated mTORC1 signaling in tumors might effectively
    eliminate radiation-induced ROS through promoting antioxidant mechanisms. However,
    inhibiting mTOR signaling might attenuate the antioxidant KEAP1-NRF2 pathway.
    Therefore, blockade of mTOR signaling in tumors might be an alternative strategy
    to increase tumor susceptibility to radiation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sirolimus
  - Everolimus
  - Temsirolimus
  - Ridaforolimus
  - GSH
---
